A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia | |
Zhao, Xu; Wu, Ju-Fang; Xiu, Qing-Yu; Wang, Chen; Zhang, De-Ping; Huang, Jian-An; Xie, Can-Mao; Sun, Sheng-Hua; Lv, Xiao-Ju; Si, Bin | |
刊名 | Diagnostic Microbiology and Infectious Disease
![]() |
2014 | |
卷号 | 80期号:2页码:141-147 |
关键词 | Community-acquired pneumonia Levofloxacin Clinical trial Efficacy Safety |
ISSN号 | 0732-8893 |
DOI | 10.1016/j.diagmicrobio.2013.11.008 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000342329200010 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3344632 |
专题 | 中南大学 |
作者单位 | 1.[Wu, Ju-Fang 2.Zhao, Xu 3.Zhang, Ying-Yuan] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200040, Peoples R China. |
推荐引用方式 GB/T 7714 | Zhao, Xu,Wu, Ju-Fang,Xiu, Qing-Yu,et al. A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia[J]. Diagnostic Microbiology and Infectious Disease,2014,80(2):141-147. |
APA | Zhao, Xu.,Wu, Ju-Fang.,Xiu, Qing-Yu.,Wang, Chen.,Zhang, De-Ping.,...&Zhang, Ying-Yuan.(2014).A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.Diagnostic Microbiology and Infectious Disease,80(2),141-147. |
MLA | Zhao, Xu,et al."A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia".Diagnostic Microbiology and Infectious Disease 80.2(2014):141-147. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论